Note 9 - Segment Information - Operations by Business Segment (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended	6 Months Ended
Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Contract Manufacturing	$ 10,290us-gaap_SalesRevenueNet	$ 8,788us-gaap_SalesRevenueNet	$ 18,872us-gaap_SalesRevenueNet	$ 17,979us-gaap_SalesRevenueNet
Contract Manufacturing	1,256us-gaap_GrossProfit	1,469us-gaap_GrossProfit	2,556us-gaap_GrossProfit	3,066us-gaap_GrossProfit
Contract Manufacturing	70us-gaap_Depreciation	66us-gaap_Depreciation	131us-gaap_Depreciation	135us-gaap_Depreciation
Contract Manufacturing	23	105	375	105
UNITED STATES
Contract Manufacturing	8,178	5,618	14,477	11,723
International Customers [Member]
Contract Manufacturing	2,112	3,170	4,395	6,256
Branded Proprietary Products [Member]
Contract Manufacturing	145	452	484	744
Contract Manufacturing	(76)	107	(70)	164
Contract Manufacturing		1	1	1
Contract Manufacturing			1
Branded Proprietary Products [Member] \| UNITED STATES
Contract Manufacturing	69	130	198	262
Branded Proprietary Products [Member] \| International Customers [Member]
Contract Manufacturing	76	322	286	482
Contract Manufacturing [Member]
Contract Manufacturing	9,642	7,792	17,450	16,083
Contract Manufacturing	1,134	1,208	2,285	2,574
Contract Manufacturing	69	63	129	129
Contract Manufacturing	23	103	374	103
Contract Manufacturing [Member] \| UNITED STATES
Contract Manufacturing	7,636	4,973	13,379	10,402
Contract Manufacturing [Member] \| International Customers [Member]
Contract Manufacturing	2,006	2,819	4,071	5,681
Other Nutraceutical Business [Member]
Contract Manufacturing	503	544	938	1,152
Contract Manufacturing	198	154	341	328
Contract Manufacturing	1	2	1	5
Contract Manufacturing		2		2
Other Nutraceutical Business [Member] \| UNITED STATES
Contract Manufacturing	473	515	900	1,059
Other Nutraceutical Business [Member] \| International Customers [Member]
Contract Manufacturing	$ 30	$ 29	$ 38	$ 93

The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name:	us-gaap_Depreciation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

+ Details

Name:	us-gaap_GrossProfit
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireProductiveAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name:	us-gaap_SalesRevenueNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=inbp_BrandedProprietaryProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=inbp_ContractManufacturingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=inbp_OtherNutraceuticalBusinessMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=inbp_InternationalCustomersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: